GPC3-targeted PET/CT

1

Review clinical trials related to GPC3-targeted PET/CT. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

GPC3-Targeted PET/CT in Hepatocellular Carcinoma

The objective of the study is to evaluate the diagnostic value of GPC3-targeted PET/CT in patients with suspected or histologically/clinically confirmed hepatocellular carcinoma, and to compare with contrast-enhanced MRI.

Participants needed: 40
Trial details
Age: 18-90Biological sex: AllType: InterventionalSponsor: The First Affiliated Hospital of Xiamen UniversityUpdated: Sep 10, 2026Locations: 1
Eligibility criteria

Adult patients (aged 18 years or older); [+3]

Lack of contrast-enhanced liver MRI or an interval of more than 14 days between... [+3]